1. Suh KS. Discovery of novel biomarkers for the development of personalized medicine. Translational Medicine. 2012; S1:e1-e2.
2. Rabbani B, Nakaoka H, Akhondzadeh S, Tekin M, Mahdieh N. Next generation sequencing: Implications in personalized medicine and pharmacogenomics. Mol Biosyst. 2016; 12(6):1818-1830. doi: 10.1039/c6mb00115g
3. Wong MG, Pollock CA. Biomarkers in kidney fibrosis: Are they useful? Kidney Int Suppl (2011). 2014; 4(1): 79-83. doi: 10.1038/kisup.2014.15
4. Wasung ME, Chawla LS, Madero M. Biomarkers of renal function, which and when? Clin Chim Acta. 2015; 438: 350-357. doi: 10.1016/j.cca.2014.08.039
5. Breit M, Weinberger KM. Metabolic biomarkers for chronic kidney disease. Arch Biochem Biophys. 2016; 589: 62-80. doi: 10.1016/j.abb.2015.07.018
6. Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: A systematic review. JAMA. 2015; 313(8): 837-846. doi: 10.1001/jama.2015.0602
7. Lopez-Giacoman S, Madero M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol. 2015; 4(1): 57-73. doi: 10.5527/wjn.v4.i1.57
8. Ye L, Mao W. Metabonomic biomarkers for risk factors of chronic kidney disease. Int Urol Nephrol. 2016; 48: 547-552. doi: 10.1007/s11255-016-1239-6
9. Simpson K, Wonnacott A, Fraser DJ, Bowen T. MicroRNAs in diabetic nephropathy: From biomarkers to therapy. Curr Diab Rep. 2016; 16: 35. doi: 10.1007/s11892-016-0724-8
10. Gohda T, Niewczas MA, Ficociello LH, et al. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol. 2012; 23: 516-524. doi: 10.1681/ASN.2011060628
11. Wong MG, Perkovic V, Woodward M, et al. Circulating bone morphogenetic protein-7 and transforming growth factor-beta1 are better predictors of renal end points in patients with type 2 diabetes mellitus. Kidney Int. 2013; 83: 278-284. doi: 10.1038/ki.2012.383
12. Cayer D, Nazor KL, Schork NJ. Mission critical: The need for proteomics in the era of next-generation sequencing and precision medicine. Hum Mol Genet. 2016. doi: 10.1093/hmg/ddw214
13. Metzker ML. Sequencing technologies – the next generation. Nat Rev Genet. 2010; 11: 31-46. doi: 10.1038/nrg2626
14. Trujillano D, Bullich G, Ossowski S, et al. Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing. Mol Genet Genomic Med. 2014; 2: 412-421. doi: 10.1002/mgg3.82
15. Zhan Y, Guo W, Zhang Y, Wang Q, Xu X-J, Zhu L. A Five Gene signature predicts prognosis in patients with kidney renal clear cell carcinoma. Comput Math Methods Med. 2015; 842784: 7. doi: 10.1155/2015/842784
16. Westland R, Sanna-Cherchi S. Recessive mutations in CAKUT and VACTERL association. Kidney Int. 2014; 85: 1253-1255. doi: 10.1038/ki.2013.495
17. Wang JJ, Mao JH. The etiology of congenital nephrotic syndrome: Current status and challenges. World J Pediatr. 2016; 12(2): 149-158. doi: 10.1007/s12519-016-0009-y
18. Nassirpour R, Mathur S, Gosink MM, et al. Identification of tubular injury microRNA biomarkers in urine: Comparison of next-generation sequencing and qPCR-based profiling platforms. BMC Genomics. 2014; 15: 485. doi: 10.1186/1471-2164-15-485
19. Tavira B, Gómez J, Diaz-Corte C, et al. ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: A next generation sequencing approach. Clin Chem Lab Med. 2015; 53: 1515-1519. doi: 10.1515/cclm-2014-1195
20. Sahoo MK, Tan SK, Chen SF, et al. Limited variation in BK virus T-cell epitopes revealed by next-generation sequencing. J Clin Microbiol. 2015; 53: 3226-3233. doi: 10.1128/JCM.01385-15
21. Ball MW, Gorin MA, Guner G, et al. Circulating tumor DNA as a marker of therapeutic response in patients with renal cell carcinoma: A pilot study. Clin Genitourin Cancer. 2016. doi: 10.1016/j.clgc.2016.03.019
22. Brennan EP, Morine MJ, Walsh DW, et al. Next-generation sequencing identifies TGF-beta1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy. Biochim Biophys Acta. 2012; 1822: 589-599. doi: 10.1016/j.bbadis.2012.01.008
23. Albert GI, Schell C, Kirschner KM, et al. The GYF domain protein CD2BP2 is critical for embryogenesis and podocyte function. J Mol Cell Biol. 2015; 7(5): 402-414. doi: 10.1093/jmcb/mjv039
24. Yang W, Yoshigoe K, Qin X, et al. Identification of genes and pathways involved in kidney renal clear cell carcinoma. BMC Bioinformatics. 2014; 15(Suppl 17): S2. doi: 10.1186/1471-2105-15-S17-S2